Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms

Clinical trial NCT06803030 · RECRUITING

Trial details

NCT number: NCT06803030
Sponsor: Bir Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ureteral Stent-Related Symptom

Start date: 2025-08-30
Primary completion: 2025-12-01
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.